{"id":"NCT00662831","sponsor":"Pfizer","briefTitle":"Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients","officialTitle":"A 6 Month, Prospective, Randomized, Double Blind, Placebo-Controlled, Parallel Group, Multiple Center Trial To Evaluate The Efficacy And Safety Of Fragmin In The Treatment Of Chronic Neuroischaemic Foot Ulcers In Diabetic Patients","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2008-04","primaryCompletion":"2010-10","completion":"2010-10","firstPosted":"2008-04-21","resultsPosted":"2012-01-13","lastUpdate":"2018-12-19"},"enrollment":276,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetic Foot Ulcer"],"interventions":[{"type":"DRUG","name":"Fragmin/ Dalteparin Sodium","otherNames":[]},{"type":"DRUG","name":"Placebo for Fragmin/ Dalteparin Sodium","otherNames":[]}],"arms":[{"label":"Active","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study isto see the effect of Fragmin on the healing of diabetic foot ulcers by determining the number of subjects with â‰¥50% reduction in ulcer surface area including intact skin healing.","primaryOutcome":{"measure":"Number of Participants With Greater Than or Equal to 50 Percent Reduction in Ulcer Surface Area Including Intact Skin Healing","timeFrame":"Week 24 [end of treatment (EOT)] or early termination","effectByArm":[{"arm":"Dalteparin","deltaMin":68,"sd":null},{"arm":"Placebo","deltaMin":31,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":63,"countries":["Austria","Belgium","Canada","Czechia","Denmark","Finland","Germany","Greece","Italy","Lithuania","Norway","Poland","Russia","Spain","Sweden","Ukraine","United Kingdom"]},"refs":{"pmids":[],"seeAlso":["https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A6301083&StudyName=Study%20Of%20The%20Effect%20Of%20Fragmin%20In%20The%20Treatment%20Of%20Neuroischaemic%20Foot%20Ulcers%20In%20Diabetic%20Patients"]},"adverseEventsSummary":{"seriousAny":{"events":33,"n":184},"commonTop":["Skin ulcer","Infected skin ulcer","Injection site haematoma","Ulcer","Pain in extremity"]}}